ES2773756R1 - Composición farmacéutica en comprimido que comprende la forma 3 de bilastina y una carga soluble en agua - Google Patents
Composición farmacéutica en comprimido que comprende la forma 3 de bilastina y una carga soluble en aguaInfo
- Publication number
- ES2773756R1 ES2773756R1 ES201990076A ES201990076A ES2773756R1 ES 2773756 R1 ES2773756 R1 ES 2773756R1 ES 201990076 A ES201990076 A ES 201990076A ES 201990076 A ES201990076 A ES 201990076A ES 2773756 R1 ES2773756 R1 ES 2773756R1
- Authority
- ES
- Spain
- Prior art keywords
- pharmaceutical composition
- water soluble
- soluble filler
- tablet pharmaceutical
- bilastine form
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- ACCMWZWAEFYUGZ-UHFFFAOYSA-N bilastine Chemical group N=1C2=CC=CC=C2N(CCOCC)C=1C(CC1)CCN1CCC1=CC=C(C(C)(C)C(O)=O)C=C1 ACCMWZWAEFYUGZ-UHFFFAOYSA-N 0.000 title 1
- 239000000945 filler Substances 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN201711045443 | 2017-12-18 | ||
| EP18154203.6A EP3470062B1 (en) | 2017-12-18 | 2018-01-30 | Pharmaceutical tablet composition comprising bilastine polymorphic form 3 and magnesium aluminometasilicate |
| IN201811041577 | 2018-11-02 | ||
| PCT/EP2018/085448 WO2019097091A1 (en) | 2017-12-18 | 2018-12-18 | Pharmaceutical tablet composition comprising bilastine form 3 and a water-soluble filler |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| ES2773756A2 ES2773756A2 (es) | 2020-07-14 |
| ES2773756R1 true ES2773756R1 (es) | 2021-04-12 |
Family
ID=66539417
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES18827035T Active ES2864176T3 (es) | 2017-12-18 | 2018-12-18 | Composición farmacéutica en comprimido que comprende la forma 3 de bilastina y una carga soluble en agua |
| ES201990076A Withdrawn ES2773756R1 (es) | 2017-12-18 | 2018-12-18 | Composición farmacéutica en comprimido que comprende la forma 3 de bilastina y una carga soluble en agua |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES18827035T Active ES2864176T3 (es) | 2017-12-18 | 2018-12-18 | Composición farmacéutica en comprimido que comprende la forma 3 de bilastina y una carga soluble en agua |
Country Status (4)
| Country | Link |
|---|---|
| EP (1) | EP3641735B1 (es) |
| ES (2) | ES2864176T3 (es) |
| PL (1) | PL3641735T3 (es) |
| WO (1) | WO2019097091A1 (es) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025067365A1 (zh) * | 2023-09-27 | 2025-04-03 | 南京迈诺威医药科技有限公司 | 含有别孕烷醇酮衍生物的药物组合物及其用途 |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1505066A1 (en) * | 2002-04-19 | 2005-02-09 | Faes Farma, S.A. | Polymorph of acid 4-[2-[4-[1-(2-ethoxyethyl)-1h-benzimidazole-2-il]-1-piperidinyl]ethyl]-alpha, alpha-dimethyl-benzeneacetic |
| WO2017017301A1 (es) * | 2015-07-24 | 2017-02-02 | Urquima, S.A | Formas cristalinas de bilastina y procedimientos para su preparación |
| CN106692090A (zh) * | 2017-02-14 | 2017-05-24 | 万全万特制药（厦门）有限公司 | 比拉斯汀片及其制备方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2124167B1 (es) | 1996-06-04 | 1999-09-16 | Espanola Prod Quimicos | Nuevos derivados del bencimidazol con actividad antihistaminica. |
| CZ307500B6 (cs) | 2012-08-15 | 2018-10-24 | Zentiva, K.S. | Způsob přípravy derivátu 2-methyl-2´-fenylpropionové kyseliny využívající nové intermediáty |
| SK7066Y1 (sk) | 2014-01-29 | 2015-03-03 | Zentiva Ks | Kryštalický dihydrát bilastínu |
| CN104398481A (zh) | 2014-10-29 | 2015-03-11 | 万全万特制药江苏有限公司 | 比拉斯汀口崩片及其制备方法 |
| WO2017167949A1 (en) | 2016-04-01 | 2017-10-05 | Krka, D.D., Novo Mesto | Crystalline forms of bilastine |
-
2018
- 2018-12-18 ES ES18827035T patent/ES2864176T3/es active Active
- 2018-12-18 EP EP18827035.9A patent/EP3641735B1/en active Active
- 2018-12-18 PL PL18827035T patent/PL3641735T3/pl unknown
- 2018-12-18 WO PCT/EP2018/085448 patent/WO2019097091A1/en not_active Ceased
- 2018-12-18 ES ES201990076A patent/ES2773756R1/es not_active Withdrawn
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1505066A1 (en) * | 2002-04-19 | 2005-02-09 | Faes Farma, S.A. | Polymorph of acid 4-[2-[4-[1-(2-ethoxyethyl)-1h-benzimidazole-2-il]-1-piperidinyl]ethyl]-alpha, alpha-dimethyl-benzeneacetic |
| WO2017017301A1 (es) * | 2015-07-24 | 2017-02-02 | Urquima, S.A | Formas cristalinas de bilastina y procedimientos para su preparación |
| CN106692090A (zh) * | 2017-02-14 | 2017-05-24 | 万全万特制药（厦门）有限公司 | 比拉斯汀片及其制备方法 |
Non-Patent Citations (1)
| Title |
|---|
| Neusilin® The Extraordinary Excipient for Oral Solid Dosage Forms; . [en línea][recuperado el 27.04.2017]. Recuperado de Internet (URL:https://www.fujichemical.co.jp/english/newsletter/newsletter_pharma_0711.html), * |
Also Published As
| Publication number | Publication date |
|---|---|
| ES2864176T3 (es) | 2021-10-13 |
| EP3641735B1 (en) | 2021-02-24 |
| EP3641735A1 (en) | 2020-04-29 |
| ES2773756A2 (es) | 2020-07-14 |
| PL3641735T3 (pl) | 2021-09-06 |
| WO2019097091A1 (en) | 2019-05-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO2022059I1 (no) | Lenacapavir or a pharmaceutically acceptable salt thereof, in particular lenacapavir sodium | |
| EP3621621C0 (en) | PHARMACEUTICAL COMPOSITIONS CONTAINING MELOXICAM | |
| EP3881846C0 (en) | PHARMACEUTICAL COMPOSITION COMPRISING PARP INHIBITORS | |
| FIC20260003I1 (fi) | Elintsanetantti tai sen farmaseuttisesti hyväksyttävä suola | |
| EP3641771A4 (en) | PHARMACEUTICAL COMPOSITIONS | |
| EP4072520C0 (en) | PHARMACEUTICAL COMPOSITIONS CONTAINING CABOTEGRAVIR | |
| ECSP17084331A (es) | Formulaciones farmacéuticas | |
| EP3454899C0 (en) | PHARMACEUTICAL COMPOSITION | |
| EP3661489A4 (en) | COMPOSITION OF FLOTTABLE PHARMACEUTICAL MICROCAPSULE | |
| EP3549585A4 (en) | ORODISPERSIBLE TABLET CONTAINING A DIAMINE DERIVATIVE | |
| DK3709978T3 (da) | Farmaceutisk oral formulering omfattende bakterier | |
| ITUB20159380A1 (it) | Dispositivo di rilevamento pressione dotato di una cavita' e relativi metodi | |
| MA44720A (fr) | Comprimés à désintégration orale | |
| EP3784214C0 (en) | ORAL LIQUID PHARMACEUTICAL DOSAGE FORM | |
| EP3583943A4 (en) | PHARMACEUTICAL COMPOSITION | |
| EP3826627C0 (de) | Oral applizierbare pharmazeutische darreichungsform mit modifizierter freisetzung | |
| EP3746080A4 (en) | PHARMACEUTICAL FORMULATIONS | |
| EP3646867C0 (en) | PHARMACEUTICAL COMPOSITION | |
| PL3694522T3 (pl) | Dwuwarstwowa formulacja tabletki farmaceutycznej | |
| CL2016002792A1 (es) | Composición en forma de una emulsión aceite en agua que comprende semilla de mostaza blanca o amarilla molida | |
| EP3375438A4 (en) | THREE-LAYER PREGABAL-CONTAINING RETARD TABLET FOR ORAL ADMINISTRATION | |
| EP3727485C0 (en) | PHARMACEUTICAL COMPOSITION | |
| ES2773756R1 (es) | Composición farmacéutica en comprimido que comprende la forma 3 de bilastina y una carga soluble en agua | |
| LT3601277T (lt) | Farmacinė vaisto forma | |
| IL283719A (en) | Colonic drug delivery formulation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| BA2A | Patent application published |
Ref document number: 2773756 Country of ref document: ES Kind code of ref document: A2 Effective date: 20200714 |
|
| EC2A | Search report published |
Ref document number: 2773756 Country of ref document: ES Kind code of ref document: R1 Effective date: 20210405 |
|
| FA2A | Application withdrawn |
Effective date: 20210727 |